Profound Medical Corp.(PROF)

$7.41—

Chart

Profound Medical Corp.(PROF)

NASDAQ

$7.41—

Chart Studio

PROF(PROF)

PROF

Overview Notebook Intelligence Chart History Fundmntls TTM Earnings Analysts News Financials Segments Insiders Institl.DCF Peers

Q3 2026 EPS Estimate

$-0.22

Aug 13, 2026 · Reports after close

Revenue Estimate

$5M

FY2028E EPS$0.39

FY2029E EPS$0.71

Analyst Sentiment

Wall St. Consensus

Buy

7 analysts·Limited coverage

Score

6 Buy (86%)1 Hold (14%)0 Sell (0%)

Rating Breakdown

Strong Buy

00%

Buy

686%

Hold

114%

Sell

00%

Strong Sell

00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear

$12.00

+62.1%

Consensus

$12.00

+62.1%

Bull

$17.00

+129.6%

12-Month Target Range7 analysts

$12.00$12.00$17.00

Current $7.41Consensus

Current Price

$7.41

Upside to Consensus

$4.59

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)

FY2027

Rev+69.29%

EPS—

FY2028

Rev+64.45%

EPS—

FY2029

Rev+46.26%

EPS+82.05%

Raw consensus estimates (low / average / high) from covering analysts.

Annual

Metric	FY2026E	FY2027E	FY2028E	FY2029E	FY2030E
Revenue Avg	$26M	$44M	$73M	$106M	$140M
Low	$26M	$41M	$69M	$101M	$134M
High	$27M	$50M	$80M	$116M	$153M
EBITDA Avg	$-26M	$-44M	$-73M	$-106M	$-140M
Low	$-27M	$-50M	$-80M	$-116M	$-153M
High	$-26M	$-41M	$-69M	$-101M	$-134M
EBIT Avg	$-26M	$-44M	$-73M	$-106M	$-140M
Low	$-27M	$-50M	$-80M	$-116M	$-153M
High	$-26M	$-41M	$-69M	$-101M	$-134M
Net Income Avg	$-26M	$-23M	$12M	$21M	$33M
Low	$-26M	$-42M	$11M	$20M	$31M
High	$-25M	$-8M	$13M	$24M	$37M
EPS Avg	$-0.84	$-0.75	$0.39	$0.71	$1.08
Low	$-0.87	$-1.37	$0.37	$0.67	$1.01
High	$-0.82	$-0.25	$0.44	$0.80	$1.21
Analysts (Rev / EPS)	3 / 4	4 / 4	2 / 3	3 / 2	3 / 2

Quarterly

Metric	Q3 2026	Q4 2026	Q1 2027	Q2 2027	Q3 2027	Q4 2027	Q1 2028	Q2 2028
Revenue Avg	$7M	$9M	$8M	$9M	$11M	$15M	$15M	$17M
Low	$5M	$7M	$7M	$8M	$10M	$12M	$13M	$15M
High	$8M	$10M	$9M	$11M	$13M	$17M	$18M	$20M
EBITDA Avg	$-7M	$-9M	$-8M	$-9M	$-11M	$-15M	$-15M	$-17M
Low	$-8M	$-10M	$-9M	$-11M	$-13M	$-17M	$-18M	$-20M
High	$-5M	$-7M	$-7M	$-8M	$-10M	$-12M	$-13M	$-15M
EBIT Avg	$-7M	$-9M	$-8M	$-9M	$-11M	$-15M	$-15M	$-17M
Low	$-8M	$-10M	$-9M	$-11M	$-13M	$-17M	$-18M	$-20M
High	$-5M	$-7M	$-7M	$-8M	$-10M	$-12M	$-13M	$-15M
Net Income Avg	$-9M	$-8M	$-7M	$-8M	$-6M	$-5M	$725,953	$1M
Low	$-10M	$-10M	$-9M	$-9M	$-8M	$-6M	$589,104	$1M
High	$-8M	$-6M	$-6M	$-6M	$-5M	$-4M	$892,216	$2M
EPS Avg	$-0.24	$-0.22	$-0.20	$-0.21	$-0.17	$-0.13	$0.02	$0.04
Low	$-0.26	$-0.27	$-0.25	$-0.26	$-0.22	$-0.15	$0.02	$0.03
High	$-0.22	$-0.18	$-0.16	$-0.17	$-0.14	$-0.10	$0.02	$0.05
Analysts (Rev / EPS)	3 / 3	2 / 1	1 / 1	2 / 1	2 / 1	1 / 1	1 / 1	1 / 1

Earnings Surprises

Recent Analyst Actions

Jan 7, 2026Lake Street

Profound Medical price target raised to $12 from $11 at Lake Street

Target:$12.00

+50.9%from $7.95

Dec 2, 2024Loop Capital Markets

Profound Medical Corp. (PROF) PT Raised to $17 at Lake Street Capital Markets

Target:$17.00

+111.8%from $8.03

Jul 23, 2024Lake Street

Profound Medical initiated with a Buy at Lake Street

Target:$16.50

+60.5%from $10.28

Jul 15, 2024Stifel Nicolaus

Stifel Upgrades Profound Medical Corp. (PROF) to Buy

Target:$12.00

+31.1%from $9.15

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance